Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Zinc oxide; Manganese carbonate; Copper(II) carbonate; Sodium selenite
Warburton Technology Limited
QA12CX99
Zinc oxide; Manganese carbonate; Copper(II) carbonate; Sodium selenite
60, 10, 15, 5 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
other mineral products, combinations
Vitamins and minerals
Authorised
2015-07-10
Health Products Regulatory Authority 22 April 2021 CRN00C20G Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Multimin Solution for Injection for Cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES: Zinc 60 mg (equivalent to zinc oxide: 74.68 mg) Manganese 10 mg (equivalent to manganese carbonate: 20.92 mg) Copper 15 mg (equivalent to copper carbonate; 26.09 mg) Selenium 5 mg (equivalent to sodium selenite: 10.95 mg) EXCIPIENTS: Benzyl alcohol (E1519) 10.4 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear blue solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Supply of trace minerals to correct concurrent clinical or subclinical deficiencies of selenium, copper, manganese and zinc which can arise during critical phases of the production or breeding life cycle. 4.3 CONTRAINDICATIONS Do not administer intramuscularly. Do not use in cases of known hypersensitivity to the active substances or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Additional copper, zinc, manganese or selenium should not be administered at the same time. Special precautions to be taken by the person administering the veterinary medicinal product to animals Health Products Regulatory Authority 22 April 2021 CRN00C20G Page 2 of 5 This product is HIGHLY concentrated in Selenium. Due to a potential risk of Selenium toxicity, care should be taken when handling the product to avoid accidental self-injection. The most common manifestations of accidental exposure to selenium in humans are gastrointestinal and neurological symptoms, such as nausea, vomiting, tenderness, fatigue and irritability. When treati Read the complete document